RAPID IDENTIFICATION OF CLINICALLY SIGNIFICANT SPECIES AND TAXA OF AEROBIC ACTINOMYCETES, INCLUDING ACTINOMADURA, GORDONA, NOCARDIA, RHODOCOCCUS, STREPTOMYCES, AND TSUKAMURELLA ISOLATES, BY DNA AMPLIFICATION AND RESTRICTION-ENDONUCLEASE ANALYSIS
Va. Steingrube et al., RAPID IDENTIFICATION OF CLINICALLY SIGNIFICANT SPECIES AND TAXA OF AEROBIC ACTINOMYCETES, INCLUDING ACTINOMADURA, GORDONA, NOCARDIA, RHODOCOCCUS, STREPTOMYCES, AND TSUKAMURELLA ISOLATES, BY DNA AMPLIFICATION AND RESTRICTION-ENDONUCLEASE ANALYSIS, Journal of clinical microbiology, 35(4), 1997, pp. 817-822
A previously described PCR-restriction fragment length polymorphism (R
FLP) identification schema for Nocardia that used an amplified 439-bp
segment (amplicon) of the 65-kDa heat shock protein gene was evaluated
for potential use with isolates of all clinically significant aerobic
actinomycetes. The study included 28 reference (American Type Culture
Collection) strains and 198 clinical isolates belonging to 20 taxonom
ic groups. Of these 198 isolates, 188 could be differentiated by this
PCR-RFLP method. Amplicons from all aerobic actinomycete isolates lack
ed BstEII recognition sites, thereby distinguishing them from those of
mycobacteria that contain one or more such sites. Of 29 restriction e
ndonucleases, MspI plus HinfI produced RFLP patterns that differentiat
ed 16 of the 20 taxa. A single RFLP pattern was observed for 15 of 20
taxa that included 65% of phenotypically clustered isolates. Multiple
patterns were seen with Gordona bronchialis, Nocardia asteroides compl
ex type VI, Nocardia otitidiscaviarum, Nocardia transvalensis, and Str
eptomyces spp. Streptomyces RFLP patterns were the most heterogeneous
(five patterns among 19 isolates), but exhibited a unique HinfI fragme
nt of >320 bp. RFLP patterns that matched those from type strains of S
treptomyces albus, Streptomyces griseus, or Streptomyces somaliensis w
ere obtained from 14 of 19 Streptomyces isolates. Only 10 of 28 isolat
es of N. otitidiscaviarum failed to yield satisfactory amplicons, whil
e only 6 of 188 (3.2%) clinical isolates exhibited patterns that faile
d to match one of the 21 defined RFLP patterns. These studies extended
the feasibility of using PCR-RFLP analysis as a rapid method for the
identification of all clinically significant species and taxa of aerob
ic actinomycetes.